跳至主要内容
临床试验/NCT03105765
NCT03105765已完成不适用

Effects of Prophylactic Administration of Ketamine on Acute and Chronic Pain After Thoracotomy for Lung Cancer, a Double Blind Randomised Trial.

Dr. Horst Schmidt Klinik GmbH1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
Change in acute pain

研究概览

简要总结

Chronic Pain, especially neuropathic pain, are adverse events after posterolateral thoracotomy for lung resection. The continuous application of ketamine may have a prophylactic effect and helps to prevent chronic pain. The investigators record the incidence and severity of acute pain and neuropathic pain during a seven day period after thoracotomy as well as the incidence of chronic pain and neuropathic pain after one and three month period. Parallel Group design, comparing one Group with a continuous application (24 hours) of ketamine against a Placebo Group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • posterolateral thoracotomy for lung parenchyma resection
  • informed consent
  • ASA (American Society of Anesthesiologists) Status I-III

排除标准

  • history of chronic pain
  • history of neuropathic pain
  • pregnancy or breastfeeding
  • participation in another trial
  • hypersensitivity for ketamine
  • medication with can influence neuropathic pain (gabapentin, clonazepam)
  • history of neurological or behavioral illness
  • history of alcohol abuse
  • history of chemotherapy or radiation
  • opioid medication

研究组 & 干预措施

Ketamine

Active Comparator

The patients in this Group underwent General anaesthesia with total intravenous anaesthesia containing remifentanil (0,02-0,04 mg/kg ideal Body weight), propofol (4-6 mg/kg ideal Body weight) and atracurium.

Ketamine 0,2 mg/kg ideal Body weight per hour for 24 hours.

干预措施: Ketamine (Drug)

Placebo

Placebo Comparator

The patients in this Group underwent General anaesthesia with total intravenous anaesthesia containing remifentanil (0,02-0,04 mg/kg ideal Body weight), propofol (4-6 mg/kg ideal Body weight) and atracurium.

Placebo (normal Saline) for 24 hours.

干预措施: Placebo (Drug)

结局指标

主要结局

Change in acute pain

时间窗: 7 days after Operation

The incidence and severity of pain will be measured using a numeric analog scale (NAS) once a day for a period of seven days after Operation.

acute neuropathic pain

时间窗: 7 days after operation

The incidence of neuropathic pain will be measured using the LANSS Pain Scale (Leeds assessment of neuropathic symptoms and signs) three and seven days after operation

Change in perioperative opioid consumption

时间窗: seven days after operation

The patients consumption of opioids is recorded once a day for a period of 7 days after operation.

次要结局

  • Chronic Neuropathic pain(one month after operation)
  • recovery time(eye opening after stopping anesthesia in minutes)
  • Change in chronic Pain(one and three month after operation)
  • Chronic Neuropathic Pain(three month after operation)

研究者

发起方
Dr. Horst Schmidt Klinik GmbH
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验